ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents

Zhao, Zean; Liu, Jin; Yuan, Lin; Yang, Zichao; Kuang, Peihua; Liao, Hui; Luo, Jian; Feng, Huancun; Zheng, Fengxin; Chen, Yongjun; Wu, Ting; Guo, Jiayin; Cao, Ying; Yang, Yang; Lin, Cuiting; Zhang, Qun*; Chen, Jianjun*; Pang, Jianxin*南方医科大学
European Journal of Medicinal Chemistry2022-11-15DOI: 10.1016/j.ejmech.2022.114682
3被引11阅读
引用收藏
分享

摘要

Benzbromarone (BM) is a potent URAT1 inhibitor approved for the treatment of gout. However, the low URAT1-selectivity and hepatotoxcity limit its clinical use. To solve these problems, we rationally designed and syn-thesized a series of BM derivatives by chemotype hybridization and bioisosteric replacement. Most compounds exhibited potent inhibitory activities against URAT1 with IC50 values ranging from 5.83 mu M to 0.80 mu M. Among them, JNS4 exhibited the highest URAT1 inhibitory activity with an IC50 of 0.80 mu M, comparable to that of BM (IC50 = 0.53 mu M). Molecular dynamic simulations showed that JNS4 formed 7C-cation interaction with R477, the same as BM. Different from BM, JNS4 bound to W357 and H245 via 7C-7C interactions and formed a hydrogen bond with S35, which might contribute to the high URAT1 binding affinity of JNS4. JNS4 hardly inhibited GLUT9 (IC50 > 20 mu M), another urate reabsorption transporter. In addition, JNS4 showed little inhibitory effects against OAT1 and ABCG2 with IC50 of 4.04 mu M and 10.16 mu M, respectively. Importantly, JNS4 displayed higher in vivo urate-lowering effects at doses of 1-4 mg/kg in a mouse model of hyperuricemia, as compared to BM and lesinurad. Furthermore, JNS4 possessed favorable pharmacokinetic properties with an oral bioavailability of 55.28%, significantly higher than that of BM (36.11%). Moreover, JNS4 demonstrated benign toxicity profiles (no cytotoxicities against HepG2 and HK2 cells; no hepatic and renal toxicities observed in vivo). Collectively, these results suggest that JNS4 represents a novel, safe and selective URAT1 inhibitor with excellent drugg-abilities and is worthy of further investigation as an anti-hyperuricemic agent.

学科与关键词

关键词
Antihyperuricemic agentsBenzbromaronePharmacokineticsToxicity
相关
加载中…
  • Design, Synthesis and Biological Activity of Low-Molecular-Weight URAT1 Inhibitors
    Chen, Siliang; Chen, Ya; Yang, Zhongcheng; Huang, Wanqiu; Cao, Zhijun; Wang, Xuekun; Yao, Huixin; Li, Zheng*; Wang, Guangji*ChemistrySelect, 2023, 8(5).
  • Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone
    Huang, Wanqiu; Jiao, Shixuan; Chen, Siliang; Chen, Ya; Yang, Zhongcheng; Wang, Wenxin; Cao, Zhijun; Li, Zheng; Zhang, Luyong*Bioorganic and Medicinal Chemistry, 2022, 75: 117073.
  • Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia
    Zhao, Zean; Liu, Jin; Kuang, Peihua; Luo, Jian; Surineni, Goverdhan; Cen, Xiaolin; Wu, Ting; Cao, Ying; Zhou, Pingzheng; Pang, Jianxin*; Zhang, Qun*; Chen, Jianjun*European Journal of Medicinal Chemistry, 2022, 229: 114092.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Medicinal Chemistry
发表日期
2022-11-15
卷期
第 242 卷
页码
114682
DOI
10.1016/j.ejmech.2022.114682
语言
MULTI-LANGUAGE
期刊等级
1区
成果收录
SCIE
资助标注
National Foundation Science of China [81773794, 81974507]; Guangzhou Science and Technology Program Project [201903010087]; scientific research project of high-level talents in Southern Medical University of China [C1051008]; Thousand Youth Talents Program from the Organization Department of the CPC Central Committee, China [C1080092]; International Science and Technology Cooperation Projects of Guang-dong Province [G819310411]

作者

  • Z

    Zhao, Zean (第一作者)

    new · southern med univ

  • L

    Liu, Jin

    new · southern med univ

查看全部 18 位作者收起作者
  • Y

    Yuan, Lin

    new · southern med univ

  • Y

    Yang, Zichao

    new · southern med univ

  • K

    Kuang, Peihua

    new · southern med univ

  • L

    Liao, Hui

    new · southern med univ

  • L

    Luo, Jian

    new · southern med univ

  • F

    Feng, Huancun

  • Z

    Zheng, Fengxin

    new · southern med univ

  • C

    Chen, Yongjun

    new · southern med univ

  • W

    Wu, Ting

    new · southern med univ

  • G

    Guo, Jiayin

    new · southern med univ

  • C

    Cao, Ying

    new · southern med univ

  • Y

    Yang, Yang

    new · southern med univ

  • L

    Lin, Cuiting

    new · southern med univ

  • Z

    Zhang, Qun (通讯)

    southern med univ

  • C

    Chen, Jianjun (通讯)

    new · southern med univ

  • P

    Pang, Jianxin (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417